2021 IVD Market Update and COVID-19 Impact

Table of Contents

ONE: WORLDWIDE IVD MARKET – 2020 UPDATE

Table 1-1: Global In Vitro Diagnostic Sales by Product Market, 2020 ($ million) (Clinical Chemistry; Immunoassays- non isotopic: Infectious disease, Other immunos, Blood bank screening, Drugs of Abuse, Diabetes HbA1c – lab; Hematology – Core Lab; Microbiology (ID/AST); Microbiology (molecular); Microbiology – Mass Spectrometry; Radioimmunoassays; Coagulation (PT/INR); Coagulation, molecular; Histology/cytology; HPV, molecular; Nucleic acid assays; Blood grouping/typing; Blood bank molecular – NAT Screens; Circulating tumor cells; POC, OTC diabetes; POC, OTC other; POC, professional/hospital; Mass Spectrometry)
COVID 19

Table 1-2: COVID-19 Product Sales – Immunoassay (Antigen, Serology), Molecular, POC), 2020 ($ millions)

IVD MARKET HIGHLIGHTS AND EFFECTS OF COVID-19

• Effect of COVID-19 on Market Segments
  • Table 1-3: IVD Market excluding and with COVID-19, 2020
  • Figure 1-1: IVD Market Distribution by Segment
  • Table 1-4: Global In Vitro Diagnostic Market – YoY Growth 2019-2020
  • Figure 1-2: Global In Vitro Diagnostic Market – YoY Growth 2019-2020
  • Figure 1-3: IVD Segment Performance, Q1 2020 – Q4 2020
  • Figure 1-4: IVD Segment Performance, Total Market Value, 2020

TWO: PRODUCT TRENDS AND NEW DEVELOPMENTS

• NEW CORE IVD PRODUCT LAUNCHES AND DEVELOPMENTS
  • Clinical Chemistry
  • Hematology
  • Oncology
  • Coagulation
  • Immunoassay
  • Microbiology
  • Histology
  • Molecular Specialties
  • POC
  • Mass Spectrometry
• COVID-19 DEVELOPMENTS – SEPTEMBER 2020 – FEBRUARY 2021
  • Figure 2-1: COVID-19 Test Market by Type, Q1-Q4 2020 – Increasing Performance in Antigen and Rapid testing; Molecular Maintains Growth; Serology Runs Steady
• Antigen
• Serology
• Molecular

THREE: SELECTED IVD MARKET PARTICIPANT DEVELOPMENTS

• SELECTED COMPETITIVE LEADER UPDATES
  • Figure 3-1: IVD Segment Growth by Leading Competitors, Change in Sales 2019-2020
  • Figure 3-2: Changes in Market Distribution for IVD Sales, 2019-2020 – Roche Maintains Lead, Abbott Closing Gap
• ABBOTT
  • Table 3-1: Abbott Corporate Summary
• AIDIAN OY
  • Table 3-2: Aidian Oy Summary
• BECTON DICKINSON AND CO
  • Table 3-3: BD Corporate Summary
• BIOMÉRIEUX SA
  • Table 3-4: bioMerieux Corporate Summary
• DANAHER
  • Table 3-5: Danaher Corporation Summary
• HOLOGIC, INC.
  • Table 3-6: Hologic Corporate Summary
• ILLUMINA
  • Table 3-7: Illumina Corporate Summary
• ORTHO CLINICAL DIAGNOSTICS
  • Table 3-8: Ortho Clinical Corporate Summary
• PERKIN ELMER
  • Table 3-9: Perkin Elmer Corporate Summary
• QUIDEL CORPORATION
  • Table 3-10 : Quidel Corporate Summary
• ROCHE DIAGNOSTIC
  • Table 3-11: Roche Diagnostic Corporate Summary
• THERMO FISHER SCIENTIFIC
  • Table 3-12: Thermo Fisher Scientific Corporate Summary

FOUR: NEW OPPORTUNITIES

• TELEHEALTH AND REMOTE PATIENT MONITORING
• EXPANDING OPTIONS IN REIMBURSEMENT
• POC